Candel Therapeutics (CADL) FCF Margin (2020 - 2022)
Candel Therapeutics (CADL) reported FCF Margin of 19138.71% for Q4 2022, up 4459462.0% on a YoY basis from N/an in Q4 2021, and up 41.55% sequentially from 32745.16% in Q3 2022.
Candel Therapeutics (CADL) FCF Margin (2020 - 2022) Analysis & Trends
Candel Therapeutics (CADL) has 3 years of FCF Margin data on file, last reported at 19138.71% in Q4 2022.
- For the quarter ending Q4 2022, FCF Margin rose 4459462.0% year-over-year to 19138.71%; the trailing twelve-month figure through Dec 2022 stood at 25393.55% (down 303496.0% YoY), and the FY2022 full-year result was 25190.4%, down 305540.0% from the prior year.
- FCF Margin rose to 19138.71% in Q4 2022, from 32745.16% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 4119.35% in Q3 2020 to a low of 63733.33% in Q4 2021.
- A 3-year average of 23955.91% and a median of 21843.55% in 2021 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin sank 5266882 bps in 2021 and surged 4459462 bps in 2022, its largest moves.
- Tracing CADL's FCF Margin over 3 years: stood at 11064.52% in 2020, then tumbled by 476 bps to 63733.33% in 2021, then soared by 70 bps to 19138.71% in 2022.
- Business Quant data shows CADL's FCF Margin at 19138.71% in Q4 2022, 32745.16% in Q3 2022, and 22354.84% in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Candel Therapeutics | 542.51 Mn | 542.51 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -19,138.71% |
| Sep 30, 2022 | -32,745.16% |
| Jun 30, 2022 | -22,354.84% |
| Mar 31, 2022 | -27,335.48% |
| Dec 31, 2021 | -63,733.33% |
| Sep 30, 2021 | -21,332.26% |
| Jun 30, 2021 | -13,616.13% |
| Mar 31, 2021 | -24,119.35% |
| Dec 31, 2020 | -11,064.52% |
| Sep 30, 2020 | -4,119.35% |